![]() |
市場調查報告書
商品編碼
1520435
2024-2032 年按材料類型、應用和地區分類的骨科生物材料市場報告Orthopedic Biomaterials Market Report by Material Type, Application, and Region 2024-2032 |
IMARC Group年全球骨科生物材料市場規模達180億美元。不斷成長的老年人口、快速的產品創新、醫療保健行業的顯著成長、各種政府舉措的實施以及廣泛的研發 (R&D) 活動是推動市場的一些關鍵因素。
骨科生物材料是骨科手術中用於替代或修復受損骨或關節組織的物質。它們是合成的或天然的,旨在模仿骨骼和關節組織的特性。陶瓷和生物活性玻璃、聚合物、磷酸鈣水泥、金屬和複合材料是一些常見的材料類型。骨科生物材料廣泛用於關節置換手術,例如髖關節、膝關節和肩關節置換、骨折固定、脊椎植入、骨移植和軟組織修復。它們具有高強度、延展性、斷裂韌性、硬度、耐腐蝕性、成型性和生物相容性。
全球不斷成長的老年人口容易遭受骨關節炎、骨質疏鬆症和骨折等各種肌肉骨骼疾病的風險,這是推動市場成長的關鍵因素之一。與此一致的是,運動傷害、退化性關節疾病和創傷性骨折等骨科疾病和損傷的日益流行,有利於市場的成長。此外,人們對骨科疾病的認知不斷提高以及先進治療解決方案的可用性是另一個促進成長的因素。除此之外,先進生物材料的引入提供了增強的生物相容性、耐用性、機械強度以及與自然組織的融合,提高了骨科植入物的成功率和壽命,為市場成長提供了動力。此外,利用源自天然來源並用於骨科以促進組織再生和癒合的可生物分解材料也有助於市場成長。此外,由於微創(MI)手術具有切口更小、恢復更快、疼痛減輕和住院時間更短等優點,對市場的成長產生了積極影響。其他因素,包括消費者支出能力的提高、廣泛的研發(R&D) 活動、對醫療保健基礎設施和服務的投資不斷增加,以及鼓勵醫療保健提供者和患者選擇骨科生物材料和手術的各種政府舉措的實施,都在支持市場成長。
The global orthopedic biomaterials market size reached US$ 18.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 40.9 Billion by 2032, exhibiting a growth rate (CAGR) of 9.22% during 2024-2032. The rising geriatric population, rapid product innovations, significant growth in the healthcare industry, the implementation of various government initiatives, and extensive research and development (R&D) activities are some of the key factors driving the market.
Orthopedic biomaterials are substances used in orthopedic surgery to replace or repair damaged bone or joint tissues. They are either synthetic or natural and are designed to mimic the properties of bone and joint tissues. Ceramics and bioactive glasses, polymers, calcium phosphate cement, metal, and composites are some of the common types of materials. Orthopedic biomaterials are widely used for joint replacement surgeries, such as hip, knee, and shoulder replacements, fracture fixations, spinal implants, bone grafting, and soft tissue repair. They exhibit high strength, ductility, fracture toughness, hardness, corrosion resistance, formability, and biocompatibility.
The rising geriatric population across the globe prone to the risk of various musculoskeletal disorders, such as osteoarthritis, osteoporosis, and fractures is one of the key factors propelling the market growth. In line with this, the increasing prevalence of orthopedic conditions and injuries, such as sports injuries, degenerative joint diseases, and traumatic fractures, is favoring the market growth. Moreover, the growing awareness about orthopedic disorders and the availability of advanced treatment solutions is acting as another growth-inducing factor. Apart from this, the introduction of advanced biomaterials that offer enhanced biocompatibility, durability, mechanical strength, and integration with natural tissues, improving the success rates and longevity of orthopedic implants, is providing an impetus to the market growth. Additionally, the utilization of biodegradable materials that are derived from natural sources and are used in orthopedics to promote tissue regeneration and healing is contributing to the market growth. Furthermore, the increasing demand for minimally invasive (MI) surgeries due to their advantages, such as smaller incisions, faster recovery, reduced pain, and shorter hospital stays, is positively impacting the market growth. Other factors, including rising expenditure capacities of consumers, extensive research and development (R&D) activities, growing investments in healthcare infrastructure and services, and the implementation of various government initiatives that encourage healthcare providers and patients to opt for orthopedic biomaterials and procedures, are supporting the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global orthopedic biomaterials market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on material type and application.
Ceramics and Bioactive Glasses
Polymers
Calcium Phosphate Cement
Metal
Composites
The report has provided a detailed breakup and analysis of the orthopedic biomaterials market based on the material type. This includes ceramics and bioactive glasses, polymers, calcium phosphate cement, metal, and composites. According to the report, ceramics and bioactive glasses represented the largest segment.
Orthopedic Implants
Joint Replacement/Reconstruction
Orthobiologics
Viscosupplementation
Bio-Resorbable Tissue Fixation
The report has provided a detailed breakup and analysis of the orthopedic biomaterials market based on the application. This includes orthopedic implants, joint replacement/reconstruction, orthobiologics, viscosupplementation, and bio-resorbable tissue fixation. According to the report, orthopedic implants represented the largest segment.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for orthopedic biomaterials. Some of the factors driving the North America orthopedic biomaterials market included the rising geriatric population, various technological advancements, and growing expenditure capacities of consumers.
The report has also provided a comprehensive analysis of the competitive landscape in the global orthopedic biomaterials market. Detailed profiles of all major companies have been provided. Some of the companies covered include Arthrex Inc., Berkeley Advanced Biomaterials, CAM Bioceramics B.V., Collagen Matrix Inc., CoorsTek Inc., Evonik Industries AG (RAG-Stiftung), Exactech Inc., Globus Medical Inc., Invibio Ltd. (Victrex plc), Koninklijke DSM N.V., Medical Devices Business Services Inc., Stryker Corporation, Zimmer Biomet, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.